45: Gray Zone Lymphoma
Gray Zone Lymphoma Caron A. Jacobson1 and Ann S. LaCasce2 1Dana-Farber Cancer Institute, Boston, MA, USA 2Dana-Farber/Partners CancerCare, Boston, MA, USA Case study 45.1 A 62-year-old woman presents to the…
44: Burkitt Lymphoma
Burkitt Lymphoma Mark Roschewski and Wyndham Wilson National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Case study 44.1 A 55-year-old man presents to the emergency department with the…
43: Primary Mediastinal Large B-Cell Lymphoma
Primary Mediastinal Large B-Cell Lymphoma Pier Luigi Zinzani Institute of Hematology “Seràgnoli,” University of Bologna, Bologna, Italy Primary mediastinal large B-cell lymphoma (PMLBCL) is a subtype of diffuse large B-cell…
12: Relapsed and Refractory Acute Myeloid Leukemia
Relapsed and Refractory Acute Myeloid Leukemia Stefan H. Faderl Hackensack University Medical Center, Hackensack, NJ, USA Case study 12.1 A 54-year-old woman is diagnosed with acute myeloid leukemia (AML). The…
42: Marginal Zone Lymphoma
Marginal Zone Lymphoma Sarah Rutherford, Wayne Tam, and Peter Martin Weill Cornell Medical College, New York, NY, USA 1. How is marginal zone lymphoma (MZL) distinguished from other non-Hodgkin’s lymphomas (NHLs)?…
2: Prognostic Markers and Models in Acute Lymphoblastic Leukemia
Prognostic Markers and Models in Acute Lymphoblastic Leukemia Dieter Hoelzer University Hospital, Frankfurt am Main, Germany Acute lymphoblastic leukemia (ALL) is not a uniform disease but is characterized by subgroups…
39: Follicular Lymphoma
Follicular Lymphoma Myron S. Czuczman Roswell Park Cancer Institute, Buffalo, NY, USA Case study 39.1 A 75-year-old retired schoolteacher notes an increase in some nontender bilateral neck lymph nodes (LNs)…
40: Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center, and Weill-Cornell Medical Center, New York, NY, USA Introduction Diffuse large B-cell lymphoma (DLBCL) is the most common…
27: Eosinophilic Myeloproliferative Disorders
Eosinophilic Myeloproliferative Disorders Jason Gotlib Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA Case study 27.1 A 54-year-old man with no significant medical history reports a 3-month history…
32: Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia
Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia Michael R. Bishop The University of Chicago, Chicago, IL, USA Case study 32.1 A 56-year-old male presented for his annual physical examination. Over…
